Endometrial cancer: a review and current management strategies: part II.
Identifieur interne : 003048 ( Main/Exploration ); précédent : 003047; suivant : 003049Endometrial cancer: a review and current management strategies: part II.
Auteurs : William M. Burke [États-Unis] ; James Orr [États-Unis] ; Mario Leitao [États-Unis] ; Emery Salom [États-Unis] ; Paola Gehrig [États-Unis] ; Alexander B. Olawaiye [États-Unis] ; Molly Brewer [États-Unis] ; Dave Boruta [États-Unis] ; Thomas J. Herzog [États-Unis] ; Fadi Abu Shahin [États-Unis]Source :
- Gynecologic oncology [ 1095-6859 ] ; 2014.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Tumeurs de l'endomètre.
- étiologie : Infertilité féminine.
- Association thérapeutique, Femelle, Humains, Infertilité féminine, Stade de la tumeur, Tumeurs de l'endomètre.
English descriptors
- KwdEn :
- MESH :
- etiology : Infertility, Female.
- pathology : Endometrial Neoplasms.
- prevention & control : Infertility, Female.
- therapy : Endometrial Neoplasms.
- Combined Modality Therapy, Female, Humans, Neoplasm Staging.
Abstract
Endometrial carcinoma is the most common gynecologic malignancy. A thorough understanding of the epidemiology, pathophysiology, and management strategies for this cancer allows the obstetrician-gynecologist to identify women at increased risk, contribute toward risk reduction, and facilitate early diagnosis. The Society of Gynecologic Oncology's Clinical Practice Committee has reviewed the literature through March of 2014 and created evidence-based practice recommendations for diagnosis and treatment. The level of recommendations used is based on the method used by the U.S. Preventive Services Task Force (A: There is good evidence to support the recommendation, B: There is fair evidence to support the recommendation, C: There is insufficient evidence to support the recommendation; however, the recommendation may be made on other grounds, D: There is fair evidence against the recommendation, E: There is good evidence against the recommendation.). It is not the purpose of this document to provide a complete review of the literature on all aspects of endometrial cancer. This article examines: • Adjuvant therapy, including radiation, vaginal brachytherapy, and chemotherapy • Therapy for advanced disease, including chemotherapy and radiation therapy alone and in combination as well as hormone therapy • Treatment for synchronous endometrial and ovarian cancer • Fertility-sparing treatment • Post-treatment patient surveillance • The role of hormone replacement therapy in the development of endometrial carcinoma • Novel targeted therapies.
DOI: 10.1016/j.ygyno.2014.06.003
PubMed: 24929052
Affiliations:
- États-Unis
- Caroline du Nord, Connecticut, Floride, Massachusetts, Pennsylvanie, État de New York
- Chapel Hill (Caroline du Nord)
- Université de Caroline du Nord à Chapel Hill
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 002041
- to stream PubMed, to step Curation: 002032
- to stream PubMed, to step Checkpoint: 002032
- to stream Ncbi, to step Merge: 002534
- to stream Ncbi, to step Curation: 002534
- to stream Ncbi, to step Checkpoint: 002534
- to stream Main, to step Merge: 003190
- to stream Main, to step Curation: 003048
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Endometrial cancer: a review and current management strategies: part II.</title><author><name sortKey="Burke, William M" sort="Burke, William M" uniqKey="Burke W" first="William M" last="Burke">William M. Burke</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Valley Hospital, Paramus, NJ, USA; Columbia University Medical Center, New York, NY, USA. Electronic address: wmb7@columbia.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Valley Hospital, Paramus, NJ, USA; Columbia University Medical Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Orr, James" sort="Orr, James" uniqKey="Orr J" first="James" last="Orr">James Orr</name><affiliation wicri:level="2"><nlm:affiliation>Florida Gynecologic Oncology, Fort Myers, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Florida Gynecologic Oncology, Fort Myers, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Leitao, Mario" sort="Leitao, Mario" uniqKey="Leitao M" first="Mario" last="Leitao">Mario Leitao</name><affiliation wicri:level="2"><nlm:affiliation>Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Salom, Emery" sort="Salom, Emery" uniqKey="Salom E" first="Emery" last="Salom">Emery Salom</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Florida International University, Miami, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Florida International University, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Gehrig, Paola" sort="Gehrig, Paola" uniqKey="Gehrig P" first="Paola" last="Gehrig">Paola Gehrig</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Olawaiye, Alexander B" sort="Olawaiye, Alexander B" uniqKey="Olawaiye A" first="Alexander B" last="Olawaiye">Alexander B. Olawaiye</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Brewer, Molly" sort="Brewer, Molly" uniqKey="Brewer M" first="Molly" last="Brewer">Molly Brewer</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Boruta, Dave" sort="Boruta, Dave" uniqKey="Boruta D" first="Dave" last="Boruta">Dave Boruta</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Columbia University Medical Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Columbia University Medical Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shahin, Fadi Abu" sort="Shahin, Fadi Abu" uniqKey="Shahin F" first="Fadi Abu" last="Shahin">Fadi Abu Shahin</name><affiliation wicri:level="2"><nlm:affiliation>Florida Gynecologic Oncology, Fort Myers, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Florida Gynecologic Oncology, Fort Myers, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24929052</idno><idno type="pmid">24929052</idno><idno type="doi">10.1016/j.ygyno.2014.06.003</idno><idno type="wicri:Area/PubMed/Corpus">002041</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002041</idno><idno type="wicri:Area/PubMed/Curation">002032</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002032</idno><idno type="wicri:Area/PubMed/Checkpoint">002032</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002032</idno><idno type="wicri:Area/Ncbi/Merge">002534</idno><idno type="wicri:Area/Ncbi/Curation">002534</idno><idno type="wicri:Area/Ncbi/Checkpoint">002534</idno><idno type="wicri:Area/Main/Merge">003190</idno><idno type="wicri:Area/Main/Curation">003048</idno><idno type="wicri:Area/Main/Exploration">003048</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Endometrial cancer: a review and current management strategies: part II.</title><author><name sortKey="Burke, William M" sort="Burke, William M" uniqKey="Burke W" first="William M" last="Burke">William M. Burke</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Valley Hospital, Paramus, NJ, USA; Columbia University Medical Center, New York, NY, USA. Electronic address: wmb7@columbia.edu.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Valley Hospital, Paramus, NJ, USA; Columbia University Medical Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Orr, James" sort="Orr, James" uniqKey="Orr J" first="James" last="Orr">James Orr</name><affiliation wicri:level="2"><nlm:affiliation>Florida Gynecologic Oncology, Fort Myers, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Florida Gynecologic Oncology, Fort Myers, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Leitao, Mario" sort="Leitao, Mario" uniqKey="Leitao M" first="Mario" last="Leitao">Mario Leitao</name><affiliation wicri:level="2"><nlm:affiliation>Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Gynecology Service, Memorial Sloan Kettering Cancer Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Salom, Emery" sort="Salom, Emery" uniqKey="Salom E" first="Emery" last="Salom">Emery Salom</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Florida International University, Miami, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Florida International University, Miami, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author><author><name sortKey="Gehrig, Paola" sort="Gehrig, Paola" uniqKey="Gehrig P" first="Paola" last="Gehrig">Paola Gehrig</name><affiliation wicri:level="4"><nlm:affiliation>Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC</wicri:regionArea><placeName><region type="state">Caroline du Nord</region><settlement type="city">Chapel Hill (Caroline du Nord)</settlement></placeName><orgName type="university">Université de Caroline du Nord à Chapel Hill</orgName></affiliation></author><author><name sortKey="Olawaiye, Alexander B" sort="Olawaiye, Alexander B" uniqKey="Olawaiye A" first="Alexander B" last="Olawaiye">Alexander B. Olawaiye</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA</wicri:regionArea><placeName><region type="state">Pennsylvanie</region></placeName></affiliation></author><author><name sortKey="Brewer, Molly" sort="Brewer, Molly" uniqKey="Brewer M" first="Molly" last="Brewer">Molly Brewer</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington, CT</wicri:regionArea><placeName><region type="state">Connecticut</region></placeName></affiliation></author><author><name sortKey="Boruta, Dave" sort="Boruta, Dave" uniqKey="Boruta D" first="Dave" last="Boruta">Dave Boruta</name><affiliation wicri:level="2"><nlm:affiliation>Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA</wicri:regionArea><placeName><region type="state">Massachusetts</region></placeName></affiliation></author><author><name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name><affiliation wicri:level="2"><nlm:affiliation>Division of Gynecologic Oncology, Columbia University Medical Center, New York, NY, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Gynecologic Oncology, Columbia University Medical Center, New York, NY</wicri:regionArea><placeName><region type="state">État de New York</region></placeName></affiliation></author><author><name sortKey="Shahin, Fadi Abu" sort="Shahin, Fadi Abu" uniqKey="Shahin F" first="Fadi Abu" last="Shahin">Fadi Abu Shahin</name><affiliation wicri:level="2"><nlm:affiliation>Florida Gynecologic Oncology, Fort Myers, FL, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Florida Gynecologic Oncology, Fort Myers, FL</wicri:regionArea><placeName><region type="state">Floride</region></placeName></affiliation></author></analytic><series><title level="j">Gynecologic oncology</title><idno type="eISSN">1095-6859</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Combined Modality Therapy</term><term>Endometrial Neoplasms (pathology)</term><term>Endometrial Neoplasms (therapy)</term><term>Female</term><term>Humans</term><term>Infertility, Female (etiology)</term><term>Infertility, Female (prevention & control)</term><term>Neoplasm Staging</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Humains</term><term>Infertilité féminine ()</term><term>Infertilité féminine (étiologie)</term><term>Stade de la tumeur</term><term>Tumeurs de l'endomètre ()</term><term>Tumeurs de l'endomètre (anatomopathologie)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs de l'endomètre</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Infertility, Female</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Infertility, Female</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Endometrial Neoplasms</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Infertilité féminine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Combined Modality Therapy</term><term>Female</term><term>Humans</term><term>Neoplasm Staging</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Femelle</term><term>Humains</term><term>Infertilité féminine</term><term>Stade de la tumeur</term><term>Tumeurs de l'endomètre</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Endometrial carcinoma is the most common gynecologic malignancy. A thorough understanding of the epidemiology, pathophysiology, and management strategies for this cancer allows the obstetrician-gynecologist to identify women at increased risk, contribute toward risk reduction, and facilitate early diagnosis. The Society of Gynecologic Oncology's Clinical Practice Committee has reviewed the literature through March of 2014 and created evidence-based practice recommendations for diagnosis and treatment. The level of recommendations used is based on the method used by the U.S. Preventive Services Task Force (A: There is good evidence to support the recommendation, B: There is fair evidence to support the recommendation, C: There is insufficient evidence to support the recommendation; however, the recommendation may be made on other grounds, D: There is fair evidence against the recommendation, E: There is good evidence against the recommendation.). It is not the purpose of this document to provide a complete review of the literature on all aspects of endometrial cancer. This article examines: • Adjuvant therapy, including radiation, vaginal brachytherapy, and chemotherapy • Therapy for advanced disease, including chemotherapy and radiation therapy alone and in combination as well as hormone therapy • Treatment for synchronous endometrial and ovarian cancer • Fertility-sparing treatment • Post-treatment patient surveillance • The role of hormone replacement therapy in the development of endometrial carcinoma • Novel targeted therapies.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Caroline du Nord</li><li>Connecticut</li><li>Floride</li><li>Massachusetts</li><li>Pennsylvanie</li><li>État de New York</li></region><settlement><li>Chapel Hill (Caroline du Nord)</li></settlement><orgName><li>Université de Caroline du Nord à Chapel Hill</li></orgName></list><tree><country name="États-Unis"><region name="État de New York"><name sortKey="Burke, William M" sort="Burke, William M" uniqKey="Burke W" first="William M" last="Burke">William M. Burke</name></region><name sortKey="Boruta, Dave" sort="Boruta, Dave" uniqKey="Boruta D" first="Dave" last="Boruta">Dave Boruta</name><name sortKey="Brewer, Molly" sort="Brewer, Molly" uniqKey="Brewer M" first="Molly" last="Brewer">Molly Brewer</name><name sortKey="Gehrig, Paola" sort="Gehrig, Paola" uniqKey="Gehrig P" first="Paola" last="Gehrig">Paola Gehrig</name><name sortKey="Herzog, Thomas J" sort="Herzog, Thomas J" uniqKey="Herzog T" first="Thomas J" last="Herzog">Thomas J. Herzog</name><name sortKey="Leitao, Mario" sort="Leitao, Mario" uniqKey="Leitao M" first="Mario" last="Leitao">Mario Leitao</name><name sortKey="Olawaiye, Alexander B" sort="Olawaiye, Alexander B" uniqKey="Olawaiye A" first="Alexander B" last="Olawaiye">Alexander B. Olawaiye</name><name sortKey="Orr, James" sort="Orr, James" uniqKey="Orr J" first="James" last="Orr">James Orr</name><name sortKey="Salom, Emery" sort="Salom, Emery" uniqKey="Salom E" first="Emery" last="Salom">Emery Salom</name><name sortKey="Shahin, Fadi Abu" sort="Shahin, Fadi Abu" uniqKey="Shahin F" first="Fadi Abu" last="Shahin">Fadi Abu Shahin</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Amérique/explor/PittsburghV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003048 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003048 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Amérique
|area= PittsburghV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24929052
|texte= Endometrial cancer: a review and current management strategies: part II.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24929052" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a PittsburghV1
| This area was generated with Dilib version V0.6.38. |  |